PubRank

J S Pagano

Author PubWeight™ 241.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst 1968 21.44
2 Detection of Epstein-Barr viral genome in nonproductive cells. Nat New Biol 1971 7.91
3 Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature 1973 6.68
4 Structural polypeptides of simian virus 40. J Virol 1971 4.83
5 Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol 1972 4.66
6 Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984 4.47
7 Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol 1973 4.43
8 Analysis of simian virus 40 DNA with the restriction enzyme of Haemophilus aegyptius, endonuclease Z. J Virol 1973 3.98
9 Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A 1987 3.82
10 Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol 1967 2.95
11 Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 1984 2.81
12 IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol 1997 2.70
13 EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol 1991 2.70
14 Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol 1980 2.69
15 Reassociation kinetics for Epstein-Barr virus DNA: nonhomology to mammalian DNA and homology of viral DNA in various diseases. J Virol 1973 2.57
16 Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A 1983 2.54
17 Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med 1976 2.53
18 Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. J Virol 1987 2.33
19 Infectious poliovirus RNA: a sensitive method of assay. Virology 1965 2.28
20 Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch 1965 2.25
21 Acyclovir inhibition of Epstein-Barr virus replication. Proc Natl Acad Sci U S A 1980 2.23
22 Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol 1972 2.16
23 DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 1973 2.02
24 Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol 1974 1.99
25 Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol 1984 1.88
26 Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol 1976 1.87
27 IRF7: activation, regulation, modification and function. Genes Immun 2011 1.80
28 Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA. Virology 1979 1.80
29 The uptake of SV40 DNA by nonpermissive cells in the presence of DEAE-dextran. Biochim Biophys Acta 1971 1.76
30 The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A 1998 1.75
31 Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma. N Engl J Med 1973 1.72
32 Cytotoxicity of sesquiterpene lactones. Cancer Res 1971 1.71
33 Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection. J Virol 1972 1.70
34 Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A 2001 1.63
35 A microtiter plate technique for the agglutination typing of Diplococcus pneumoniae. J Infect Dis 1970 1.62
36 A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 1986 1.61
37 Replication of EBV in epithelial cells during infectious mononucleosis. Nature 1977 1.61
38 Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization. J Biol Chem 1980 1.57
39 Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 1983 1.57
40 Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. Am J Dis Child 1966 1.56
41 Structural proteins of simian virus 40. I. Histone characteristics of low-molecular-weight polypeptides. J Virol 1975 1.56
42 Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication. Antimicrob Agents Chemother 1987 1.55
43 Epstein-Barr virus DNA synthesized in superinfected Raji cells. Virology 1977 1.55
44 Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis. J Virol 1981 1.48
45 Autologous human B and T lymphoblastoid cell lines. Nature 1974 1.48
46 Structure and function of the polypeptides in simian virus 40. II. Transcription of subviral deoxynucleoprotein complexes in vitro. J Virol 1972 1.47
47 Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture. J Gen Virol 1979 1.46
48 Epstein-Barr virus: culprit or consort? N Engl J Med 1992 1.46
49 Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines. J Virol 1981 1.44
50 Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells. J Virol 1980 1.43
51 Biologic activity of isolated viral nucleic acids. Prog Med Virol 1970 1.40
52 Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole. J Virol 1999 1.39
53 Epstein-Barr virus-associated thymidine kinase. J Virol 1978 1.38
54 Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol 1999 1.33
55 Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol 2000 1.31
56 Regulation of the Epstein-Barr virus DNA polymerase gene. J Virol 1992 1.31
57 Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. J Immunol 1974 1.31
58 Sites of replication of chromosomal DNA in a eukaryotic cell. Proc Natl Acad Sci U S A 1972 1.29
59 Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol 1996 1.27
60 RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J Virol 1994 1.27
61 Papovaviridae. Intervirology 1974 1.26
62 Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N Engl J Med 1976 1.26
63 Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses. Am J Med 1982 1.25
64 Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7. J Virol 2001 1.23
65 Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol 1999 1.23
66 Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer 2011 1.22
67 Diseases and mechanisms of persistent DNA virus infection: latency and cellular transformation. J Infect Dis 1975 1.22
68 Detection of autonomous replicating sequences (ars) in the genome of Epstein-Barr virus. Proc Natl Acad Sci U S A 1983 1.22
69 Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. J Virol 1985 1.20
70 Dissociation of opsonized particle phagocytosis and respiratory burst activity in an Epstein-Barr virus-infected myeloid cell line. J Cell Biol 1980 1.19
71 Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned gene. J Virol 1991 1.18
72 Epstein-Barr virus: inhibition of replication by three new drugs. Science 1983 1.17
73 Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. J Virol 2001 1.16
74 Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon. Antimicrob Agents Chemother 1991 1.15
75 Simultaneous infection with multiple herpesviruses. Am J Med 1979 1.15
76 Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA. Proc Natl Acad Sci U S A 1993 1.14
77 Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol Cell Biol 1994 1.14
78 Infections with cytomegalovirus in bone marrow transplantation: report of a workshop. J Infect Dis 1975 1.13
79 The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J Virol 1998 1.11
80 Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. Virology 1989 1.11
81 Expression and localization of the Epstein-Barr virus-encoded protein kinase. J Virol 2004 1.11
82 Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus. Virology 1980 1.10
83 Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res 2000 1.09
84 Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. Virology 1982 1.08
85 Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function. J Virol 1990 1.08
86 Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency. Mol Cell Biol 1999 1.08
87 Epstein-Barr virus polypeptides: identification of early proteins and their synthesis and glycosylation. J Virol 1981 1.08
88 Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother 1985 1.07
89 Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci U S A 1993 1.07
90 The Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript. J Virol 1998 1.06
91 Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy. J Infect Dis 1994 1.04
92 Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator. Clin Exp Metastasis 1999 1.03
93 A noncanonical poly(A) signal, UAUAAA, and flanking elements in Epstein-Barr virus DNA polymerase mRNA function in cleavage and polyadenylation assays. Virology 1997 1.03
94 Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells. J Infect Dis 1993 1.03
95 Phosphorylation of acyclovir in vitro in activated Burkitt somatic cell hybrids. Antimicrob Agents Chemother 1983 1.03
96 Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother 1989 1.02
97 Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother 1983 1.00
98 The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res 1998 0.98
99 Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene 2009 0.98
100 Iodination of herpesvirus nucleic acids. J Virol 1975 0.97
101 Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function. J Virol 1986 0.97
102 Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis. J Immunol 1975 0.97
103 Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter. J Virol 1983 0.95
104 Epstein-Barr virus genome in infectious mononucleosis. Nature 1976 0.95
105 Subpopulations of human lymphoblastoid cell lines. Correlation with the expression of surface receptors and content of Epstein-Barr virus genome. Scand J Immunol 1976 0.95
106 Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine. Virology 1981 0.94
107 Field evaluation of live virus mumps vaccine. J Pediatr 1968 0.92
108 Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase. J Virol 1985 0.91
109 Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication. Antimicrob Agents Chemother 1991 0.90
110 Synthesis of Epstein-Barr virus DNA in vitro: effects of phosphonoacetic acid, N-ethylmaleimide, and ATP. J Virol 1977 0.90
111 Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res 1981 0.89
112 Cellular transformation by the herpesviruses and antiviral drugs. Pharmacol Ther 1985 0.89
113 Murine cytomegalovirus infection of epithelial cells in mouse tracheal ring organ culture. J Infect Dis 1977 0.89
114 Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation. Semin Cancer Biol 2001 0.89
115 The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line. Cancer Res 1974 0.89
116 Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine. J Infect Dis 1989 0.89
117 Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines. Antiviral Res 1985 0.88
118 Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. J Gen Virol 1989 0.87
119 T antigen of BK papovavirus in infected and transformed cells. J Virol 1978 0.87
120 Synthesis of chromosomal proteins and Epstein-Barr virus DNA in activated Burkitt somatic cell hybrids. Virology 1980 0.87
121 Replication of cytomegalovirus DNA in human lymphoblastoid cells. IARC Sci Publ 1975 0.85
122 Explantation and subculture of epithelial cells from human uterine ectocervix. Cancer Res 1980 0.85
123 The Epstein-Barr Virus and malignancy: molecular evidence. Cold Spring Harb Symp Quant Biol 1975 0.84
124 Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir. Am J Med 1982 0.84
125 Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs. Cancer Res 2001 0.83
126 Epstein-Barr virus-induced deoxynuclease and the reutilization of host-cell DNA degradation products in viral DNA replication. Virology 1981 0.83
127 Analysis of the Epstein-Barr virus origin of plasmid replication (oriP) reveals an area of nucleosome sparing that spans the 3' dyad. J Virol 1989 0.83
128 Biotin-labeled DNA probes for detection of Epstein-Barr virus by in-situ cytohybridization. Clin Lab Med 1985 0.83
129 Cultured "hairy cells" infected with Epstein-Barr virus: evidence for B-lymphocyte origin. Ann Intern Med 1979 0.82
130 Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus. Antimicrob Agents Chemother 1988 0.82
131 Letter: Vaccination against cytomegalovirus? Lancet 1974 0.82
132 Prevention of infections with cytomegalovirus. Yale J Biol Med 1976 0.82
133 Homology of Epstein-Barr virus DNA in nasopharyngeal carcinomas from Kenya, Taiwan, Singapore and Tunisia. IARC Sci Publ 1975 0.81
134 Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma. J Virol 1988 0.81
135 Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993 0.80
136 Treatment of life-threatening Epstein-Barr virus infection with acyclovir. Am J Med 1982 0.80
137 Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid. J Virol 1978 0.80
138 The specificity and interaction with poliovirus of an inhibitory bovine serum. J Immunol 1965 0.80
139 Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report. Prog Immunobiol Stand 1967 0.79
140 Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line. J Virol 1987 0.79
141 Long-term mouse cytomegalovirus infection of tracheal organ culture: relation to host cell replication. J Gen Virol 1982 0.78
142 The pathogenesis and prevention of human cytomegalovirus infection. Report of a conference. Pediatr Infect Dis 1984 0.77
143 DNA tumor viruses. Transplant Proc 1984 0.77
144 Epstein-Barr virus DNA in Hodgkin's disease, American Burkitt's lymphoma, and other human tumors. Cancer Res 1974 0.77
145 Interferon production and activation of non-specific effector cells by stimulation with lymphoblastoid cell lines in vitro. Int J Cancer 1981 0.77
146 Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probes. J Virol 1986 0.77
147 Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB). J Natl Cancer Inst 1976 0.77
148 The Epstein-Barr virus and nasopharyngeal carcinoma. Cancer 1994 0.76
149 Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. N Engl J Med 1995 0.76
150 Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy. Leukemia 1994 0.76
151 Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial. Am J Public Health 1971 0.75
152 Detection of Epstein-Barr virus DNA in human tumors. Bibl Haematol 1975 0.75
153 Viruses as oncolytic agents: a new age for "therapeutic" viruses? J Natl Cancer Inst 1994 0.75
154 Insurance coverage of screening mammography and Pap smears. The directors of North Carolina's University-based cancer centers speak out. N C Med J 1991 0.75
155 Rapid microtiter method for cytotoxicity screening. J Pharm Sci 1972 0.75
156 Use of topical acyclovir. J Am Acad Dermatol 1983 0.75
157 Epstein-Barr virus and its antigens. Immunol Ser 1989 0.75
158 Unknown hazards of infection. N Engl J Med 1968 0.75
159 Perspective on cytomegalovirus. Birth Defects Orig Artic Ser 1984 0.75
160 Type 3 poliovirus vaccines. J Pediatr 1969 0.75
161 Pneumonia. Am Fam Physician 1972 0.75
162 Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 1983 0.75
163 Enhancement of viral infectivity with DEAE-dextran: application to development of vaccines. Prog Immunobiol Stand 1967 0.75
164 A case of intrauterine fetal death after a negative oxytocin challenge test. Am J Obstet Gynecol 1978 0.75
165 Uterotubal implantation and successful pregnancy following laparoscopic tubal cauterization. Obstet Gynecol 1977 0.75
166 Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication. Antiviral Res 1992 0.75
167 Human ectocervical and endocervical epithelial cells in culture: a comparative ultrastructural study. Am J Obstet Gynecol 1980 0.75
168 Replication of Epstein-Barr virus DNA in epithelial cells in vivo. IARC Sci Publ 1978 0.75
169 Acyclovir comes of age. J Am Acad Dermatol 1982 0.75
170 Pathogenesis of infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma: a unified scheme. IARC Sci Publ 1978 0.75
171 Effect of 5-iodo-2'-deoxyuridine on physical properties and nonhistone chromosomal proteins of chromatin from Burkitt somatic cell hybrids. Arch Biochem Biophys 1980 0.75
172 Identification of LSc2ab strain of type 1 poliovirus by inhibition with horse serum and dextran sulfate. Proc Soc Exp Biol Med 1966 0.75
173 Burkitt's and other non-Hodgkin's lymphomas in adults exposed to a visitor from Africa. N Engl J Med 1985 0.75